Michael Henry Fiore - 29 May 2026 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Reporting relationship: EVP, CHIEF COMMERCIAL OFFICER
Issuer ticker: HQY
Reported as of: 29 May 2026
Net transaction value: -$298,490
SEC form: 4
Accepted by SEC: 02 Jun 2026, 17:03:25 UTC
Prior SEC filing: 08 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Fiore

Key filing fact

Michael Henry Fiore filed Form 4 for HEALTHEQUITY, INC. (HQY) on 02 Jun 2026.

Key facts

This page summarizes Michael Henry Fiore's Form 4 filing for HEALTHEQUITY, INC. (HQY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2026, 17:03.

Change

Previous filing in this sequence was filed on 08 Apr 2026.
Current net transaction value: -$298,490.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002016116 Primary reporting owner

Fiore Michael Henry

Relationship: EVP, CHIEF COMMERCIAL OFFICER
Address: C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER
Signature: /s/ Michael Fiore
Signature date: 02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Sale

Transaction value: $298,490
Shares: -3,142
Change %: -5%
Price: $95.00
Shares after: 59,113
Date: 29 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2025.